Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis.
Charat ThongprayoonPloypin LertjitbanjongWisit CheungpasitpornPanupong HansrivijitTibor FülöpKarthik KovvuruSwetha R KanduriPaul W DavisSaraschandra VallabhajosyulaTarun BathiniKanramon WatthanasuntornNarut PrasitlumkumRonpichai ChokesuwattanaskulSupawat RatanapoMichael A MaoKianoush KashaniPublished in: Renal failure (2020)
Background: We aimed to evaluate the acute kidney injury (AKI) incidence and its associated risk of mortality in patients with implantable left ventricular assist devices (LVAD).Methods: A systematic literature search in Ovid MEDLINE, EMBASE, and Cochrane Databases was conducted through January 2020 to identify studies that provided data on the AKI incidence and AKI-associated mortality risk in adult patients with implantable LVADs. Pooled effect estimates were examined using random-effects, generic inverse variance method of DerSimonian-Laird.Results: Fifty-six cohort studies with 63,663 LVAD patients were enrolled in this meta-analysis. The pooled incidence of reported AKI was 24.9% (95%CI: 20.1%-30.4%) but rose to 36.9% (95%CI: 31.1%-43.1%) when applying the standard definition of AKI per RIFLE, AKIN, and KDIGO criteria. The pooled incidence of severe AKI requiring renal replacement therapy (RRT) was 12.6% (95%CI: 10.5%-15.0%). AKI incidence did not differ significantly between types of LVAD (p = .35) or indication for LVAD use (p = .62). While meta-regression analysis did not demonstrate a significant association between study year and overall AKI incidence (p = .55), the study year was negatively correlated with the incidence of severe AKI requiring RRT (slope = -0.068, p < .001). The pooled odds ratios (ORs) of mortality at 30 days and one year in AKI patients were 3.66 (95% CI, 2.00-6.70) and 2.22 (95% CI, 1.62-3.04), respectively. The pooled ORs of mortality at 30 days and one year in severe AKI patients requiring RRT were 7.52 (95% CI, 4.58-12.33) and 5.41 (95% CI, 3.63-8.06), respectively.Conclusion: We found that more than one-third of LVAD patients develop AKI based on standard definitions, and 13% develop severe AKI requiring RRT. There has been a potential improvement in the incidence of severe AKI requiring RRT for LVAD patients. AKI in LVAD patients was associated with increased 30-day and 1 year mortality.
Keyphrases
- acute kidney injury
- end stage renal disease
- cardiac surgery
- risk factors
- ejection fraction
- left ventricular
- systematic review
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- type diabetes
- cardiovascular events
- heart failure
- machine learning
- randomized controlled trial
- cardiovascular disease
- coronary artery disease
- aortic valve
- patient reported
- study protocol
- mitral valve
- climate change
- left ventricular assist device
- hypertrophic cardiomyopathy
- meta analyses